Abigeal Dolapo Adeyemi

Dr. Abigeal Dolapo Adeyemi

Aquaculture Research Institute, University of Maine, Orono, Maine, USA
+1
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2025 in North American Journal of Aquaculture
Verified
Journal Article
Closed access
MTMagida Tabbara
Magida Tabbara
Abigeal Dolapo AdeyemiAbigeal Dolapo Adeyemi
Abigeal Dolapo Adeyemi
DDD Allen Davis
D Allen Davis
VKVikas Kumar
Vikas Kumar
Anita M. KellyAnita M. Kelly
Anita M. Kelly
Timothy J BruceTimothy J Bruce
Timothy J Bruce
Objective: We sought to assess whether incorporating the frass of black soldier fly Hermetia illucens larvae in Channel Catfish Ictalurus punctatus diets affects fish growth, serum biochemistry, intestinal histology, and survival against bacterial pathogens. Methods: Three experimental diets were formulated, with commercial black soldier fly larva frass (BSFF) added into the formulation at 0.0, 7.5, and 15.0%. Fifty Channel Catfish fingerlings (average initial weight ± SD = 3.04 ± 0.07 g) were stocked into 15 glass aquaria within an indoor recirculating aquaculture system. Diets were randomly assigned and offered to catfish in five replicate aquaria. After the conclusion of the 84-d experiment, fish were group-weighed and counted to evaluate growth and survival. In two other experiments, juvenile catfish were acclimated to the experimental diets for 90 and 47 d, respectively, and then challenged with pathogenic bacteria. Immersion challenges were performed with Edwardsiella ictaluri (3.1 × 105 CFU/mL), virulent Aeromonas hydrophila (2.7 × 107 CFU/mL), or Flavobacterium covae (1.0 × 106 CFU/mL). Results: No significant differences were observed among treatments in terms of final biomass, final weight, weight gain (%), or survival. However, fish that were offered 7.5% and 15.0% BSFF in their diets had significantly lower feed conversion ratios (1.40 and 1.46 for 7.5% and 15.0% BSFF, respectively) than fish offered the basal diet (1.58). Fish challenged with E. ictaluri exhibited better survival when offered feed with BSFF. However, the inclusion of BSFF in the diets did not significantly influence the postinfection survival of fish challenged with virulent A. hydrophila or F. covae. Conclusions: We found that BSFF can be used in Channel Catfish diets without adversely affecting growth or survival and that BSFF can also confer protective benefits to Channel Catfish against E. ictaluri.

1 January 2025 in Aquaculture Research
Verified
Journal Article
Open access
MTMagida Tabbara
Magida Tabbara
TCTrenton L. Corby
Trenton L. Corby
SNSidra Nazeer
Sidra Nazeer
Abigeal Dolapo AdeyemiAbigeal Dolapo Adeyemi
Abigeal Dolapo Adeyemi
Timothy J BruceTimothy J Bruce
Timothy J Bruce
DDDonald Allen Davis
Donald Allen Davis
Corn production in the US results in a variety of products, including ethanol and the recycling of coproducts into animal feed. Corn fermented protein (CFP) is a high‐protein, low‐fiber improved coproduct of the ethanol industry that is rich in lysine and methionine and doesn’t contain antinutritional factors. Because of these attributes, CFP is a potential candidate to replace soybean meal (SBM) whilst improving animal growth and health. Accordingly, the present work assesses the effects of CFP on channel catfish growth, whole‐body composition, overall health, and resistance to major disease‐causing bacteria. Six experimental diets were formulated to include CFP at 0%, 5%, 10%, 15%, 20%, and 30%. After feed preparation, 20 channel catfish fingerlings (2.56 ± 0.06 g) were randomly assigned to six replicate aquaria per diet. During the 70‐day experiment, catfish were weighed biweekly, and the feed ration was calculated as a percentage of the aquarium biomass and increased by 10% the following week. At termination, fish were group‐weighed, enumerated, then sampled for whole‐body proximate, serum lysozyme activity and biochemistry analyses. Subsequently, another set of catfish (5.29 ± 0.19 g) were acclimated to the diets for 42 days. Afterward, fish were challenged by immersion with Flavobacterium covae (1.00 × 10 6 CFU mL −1 ), virulent Aeromonas hydrophila (3.55 × 10 7 CFU mL −1 ), and Edwardsiella ictaluri (1.60 × 10 5 CFU mL −1 ). Results of the present work suggest that CFP can be successfully used at 30% of channel catfish diets. Fish growth, survival, protein retention, whole‐body proximate composition, serum lysozyme activity, or biochemistry were similar regardless of the CFP inclusion level ( p > 0.05). Additionally, CFP inclusion does not seem to confer protection against F. covae or virulent A. hydrophila infections but seems to change catfish survival postinfection with E. ictaluri . CFP can be successfully used as an ingredient in channel catfish diets, but the potential to protect the fish against bacterial infections needs further investigation.

1 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
KMKala Mallik Meesala
Kala Mallik Meesala
Abigeal Dolapo AdeyemiAbigeal Dolapo Adeyemi
Abigeal Dolapo Adeyemi
SJSarah Janson
Sarah Janson
JHJeongwhui Hong
Jeongwhui Hong
MPMark Polinski
Mark Polinski
Michael Habte-TsionMichael Habte-Tsion
Michael Habte-Tsion
Functional feed ingredients with antimicrobial activities are being explored as a tool to mitigate diseases in Atlantic salmon (Salmo salar L.). Skeletonema marinoi is a marine diatom known to have antimicrobial activity. Here, two separate experiments, including a growth study (Exp.1) and a bacterial challenge (Exp.2), were conducted to evaluate the effects of dietary S. marinoi as a functional feed ingredient on the growth, feed utilization, stress biomarkers, antioxidant defense, and immunogenic responses of Atlantic salmon. In Exp 1, a 16-week growth trial was conducted in a recirculating aquaculture system (RAS) stocked with ten fish (59.6 ± 1.6 g, initial weight) in each of five replicate tanks per treatment. Fish were fed twice daily with either the reference diet or the reference diet supplemented with 0.5% S. marinoi. In Exp. 2, a 27-day bacterial challenge with Vibrio anguillarum Serotype O3 (SO3) was conducted in RAS using 36 fish (100–150 g) per 150 L tank in triplicate. Fish were acclimatized to the RAS for 14 days and fed twice daily with the reference or 0.5% S. marinoi diet prior to the bacterial challenge. Blood plasma, liver, and intestine samples were collected after the growth trial, before (initial, 0 day) and post-challenge (5, 10, 27 days). The results indicated that in Exp. 1, there were no significant differences in survival, final weight, weight gain, feed intake, feed efficiency, condition factor, and hepatosomatic index between fish fed with the reference diet and 0.5% S. marinoi diet. In Exp. 2, before challenge, Atlantic salmon fed the diet with 0.5% S. marinoi showed significantly higher superoxide dismutase (SOD) activity in comparison to fish fed the reference diet. On day 5 post-challenge, significantly higher liver peroxidation or malondialdehyde (MDA) level was measured in the 0.5% S. marinoi group compared to the reference group. Plasma immunoglobulin M (IgM) level and intestinal IgM gene expression increased after challenge in fish fed 0.5% S. marinoi, in contrast to those fed the reference diet at 27 days post-challenge (P < 0.05). Overall, these findings suggest that S. marinoi is more likely to be associated with immune modulation rather than adverse stress response; however, further work is required to confirm pathogen-specific immunity.

29 July 2026 in Aquaculture Journal
Verified
Journal Article
Open access
PDF file
KMKala Mallik Meesala
Kala Mallik Meesala
Abigeal Dolapo AdeyemiAbigeal Dolapo Adeyemi
Abigeal Dolapo Adeyemi
SJSarah Janson
Sarah Janson
JHJeongwhui Hong
Jeongwhui Hong
MPMark Polinski
Mark Polinski
Michael Habte-TsionMichael Habte-Tsion
Michael Habte-Tsion
Functional feed ingredients with antimicrobial activities are being explored as a tool to mitigate diseases in Atlantic salmon (Salmo salar L.). Skeletonema marinoi is a marine diatom known to have antimicrobial activity. Here, two separate experiments, including a growth study (Exp. 1) and a bacterial challenge (Exp. 2), were conducted to evaluate the effects of dietary S. marinoi as a functional feed ingredient on the growth, feed utilization, stress biomarkers, antioxidant defense, and immunogenic responses of Atlantic salmon. In Exp. 1, a 16-week growth trial was conducted in a recirculating aquaculture system (RAS) stocked with ten fish (59.6 ± 1.6 g, initial weight) in each of five replicate tanks per treatment. Fish were fed twice daily with either the reference diet or the reference diet supplemented with 0.5% S. marinoi. In Exp. 2, a 27-day bacterial challenge with Vibrio anguillarum Serotype O3 (SO3) was conducted in RAS using 36 fish (100–150 g) per 150 L tank in triplicate. Fish were acclimatized to the RAS for 14 days and fed twice daily with the reference or 0.5% S. marinoi diet prior to the bacterial challenge. Blood plasma, liver, and intestine samples were collected after the growth trial, before (initial, 0 day) and post-challenge (5, 10, 27 days). The results indicated that in Exp. 1, there were no significant differences in survival, final weight, weight gain, feed intake, feed efficiency, condition factor, and hepatosomatic index between fish fed the reference diet and 0.5% S. marinoi diet (p > 0.05). In Exp. 2, before challenge, Atlantic salmon fed the diet with 0.5% S. marinoi showed significantly higher superoxide dismutase (SOD) activity in comparison to fish fed the reference diet. On day 5 post-challenge, significantly higher hepatic malondialdehyde (MDA) was measured in the 0.5% S. marinoi group compared to the reference group. Plasma immunoglobulin M (IgM) level increased (p < 0.05), and intestinal IgM gene expression was up-regulated after challenge in fish fed 0.5% S. marinoi, in contrast to those fed the reference diet at 27 days post-challenge (p < 0.05). Overall, these findings suggest that S. marinoi is more likely to be associated with immune modulation rather than adverse stress response; however, further work is required to confirm pathogen-specific immunity.